Work

Encouraging survival data from a phase I trial of radiation (RT) dose escalation with full dose gemcitabine (GEM) in patients with unresectable pancreatic cancer

Year: 2000

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/s0360-3016(00)80240-0

Authors: C.J. McGinn, I. Shureiqi, J.M. Robertson, F.E. Eckhauser, D.C. Smith, D.A. Decker, K.H. Neumann, D. Brown, M. Strawderman, T.S. Lawrence

Institutions: University of Michigan, Beaumont Hospital, Royal Oak

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1976331780

FWCI:

Cites:

Cited by:

Related to: 10